306 related articles for article (PubMed ID: 29992461)
1. Association between circulating visfatin and gestational diabetes mellitus: a systematic review and meta-analysis.
Zhang W; Zhao D; Meng Z; Wang H; Zhao K; Feng X; Li Y; Dun A; Jin X; Hou H
Acta Diabetol; 2018 Nov; 55(11):1113-1120. PubMed ID: 29992461
[TBL] [Abstract][Full Text] [Related]
2. Circulating visfatin levels in the second and third trimester of pregnancies with gestational diabetes: a systematic review.
Pace NP; Bonello A; Roshan MH; Vassallo J
Minerva Ginecol; 2019 Aug; 71(4):329-343. PubMed ID: 31274262
[TBL] [Abstract][Full Text] [Related]
3. Relationship of maternal serum resistin and visfatin levels with gestational diabetes mellitus.
Karatas A; Tunçay Işikkent N; Ozlü T; Demirin H
Gynecol Endocrinol; 2014 May; 30(5):355-8. PubMed ID: 24512558
[TBL] [Abstract][Full Text] [Related]
4. Visfatin level and gestational diabetes mellitus: a systematic review and meta-analysis.
Jiang YK; Deng HY; Qiao ZY; Gong FX
Arch Physiol Biochem; 2021 Oct; 127(5):468-478. PubMed ID: 33476191
[TBL] [Abstract][Full Text] [Related]
5. Placental expressions and serum levels of adiponectin, visfatin, and omentin in GDM.
Souvannavong-Vilivong X; Sitticharoon C; Klinjampa R; Keadkraichaiwat I; Sripong C; Chatree S; Sririwichitchai R; Lertbunnaphong T
Acta Diabetol; 2019 Oct; 56(10):1121-1131. PubMed ID: 31076892
[TBL] [Abstract][Full Text] [Related]
6. Serum visfatin concentrations in gestational diabetes mellitus and normal pregnancy.
Rezvan N; Hosseinzadeh-Attar MJ; Masoudkabir F; Moini A; Janani L; Mazaherioun M
Arch Gynecol Obstet; 2012 May; 285(5):1257-62. PubMed ID: 22167446
[TBL] [Abstract][Full Text] [Related]
7. Visfatin in human pregnancy: maternal gestational diabetes vis-à-vis neonatal birthweight.
Mazaki-Tovi S; Romero R; Kusanovic JP; Vaisbuch E; Erez O; Than NG; Chaiworapongsa T; Nhan-Chang CL; Pacora P; Gotsch F; Yeo L; Kim SK; Edwin SS; Hassan SS; Mittal P
J Perinat Med; 2009; 37(3):218-31. PubMed ID: 19099366
[TBL] [Abstract][Full Text] [Related]
8. Leptin, resistin and visfatin as useful predictors of gestational diabetes mellitus.
Bawah AT; Seini MM; Abaka-Yawason A; Alidu H; Nanga S
Lipids Health Dis; 2019 Dec; 18(1):221. PubMed ID: 31836012
[TBL] [Abstract][Full Text] [Related]
9. Maternal and cord blood apelin, resistin and visfatin levels in gestational diabetes mellitus.
Oncul M; Tuten A; Erman H; Gelisgen R; Benian A; Uzun H
Minerva Med; 2013 Oct; 104(5):527-35. PubMed ID: 24101110
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of visfatin and possible interaction with iron parameters in gestational diabetes mellitus.
Kaygusuz I; Gumus II; Yılmaz S; Simavlı S; Uysal S; Derbent AU; Gözdemir E; Kafalı H
Gynecol Obstet Invest; 2013; 75(3):203-9. PubMed ID: 23548246
[TBL] [Abstract][Full Text] [Related]
11. Increased visfatin concentrations in women with gestational diabetes mellitus.
Krzyzanowska K; Krugluger W; Mittermayer F; Rahman R; Haider D; Shnawa N; Schernthaner G
Clin Sci (Lond); 2006 May; 110(5):605-9. PubMed ID: 16489932
[TBL] [Abstract][Full Text] [Related]
12. Gestational diabetes is associated with high energy and saturated fat intakes and with low plasma visfatin and adiponectin levels independent of prepregnancy BMI.
Park S; Kim MY; Baik SH; Woo JT; Kwon YJ; Daily JW; Park YM; Yang JH; Kim SH
Eur J Clin Nutr; 2013 Feb; 67(2):196-201. PubMed ID: 23385969
[TBL] [Abstract][Full Text] [Related]
13. Maternal serum visfatin at 11-13 weeks of gestation in gestational diabetes mellitus.
Ferreira AF; Rezende JC; Vaikousi E; Akolekar R; Nicolaides KH
Clin Chem; 2011 Apr; 57(4):609-13. PubMed ID: 21325104
[TBL] [Abstract][Full Text] [Related]
14. [Role of visfatin in the pathogenesis of gestational diabetes mellitus and its relationship with insulin resistance].
Huo Y; Liu S; Feng J; Li H; Fan Y; Jin Y; Li L
Zhonghua Fu Chan Ke Za Zhi; 2014 Aug; 49(8):584-7. PubMed ID: 25354858
[TBL] [Abstract][Full Text] [Related]
15. Association between circulating visfatin and pre-eclampsia: a systematic review and meta-analysis.
Amiri-Dashatan N; Koushki M; Hosseini H; Khodabandehloo H; Fathi M; Doustimotlagh AH; Rezaei-Tavirani M
J Matern Fetal Neonatal Med; 2022 Jul; 35(13):2606-2618. PubMed ID: 32635792
[TBL] [Abstract][Full Text] [Related]
16. Decreased plasma visfatin concentrations in women with gestational diabetes mellitus.
Chan TF; Chen YL; Lee CH; Chou FH; Wu LC; Jong SB; Tsai EM
J Soc Gynecol Investig; 2006 Jul; 13(5):364-7. PubMed ID: 16814166
[TBL] [Abstract][Full Text] [Related]
17. Hepatokine levels during the first or early second trimester of pregnancy and the subsequent risk of gestational diabetes mellitus: a systematic review and meta-analysis.
Cai Z; Yang Y; Zhang J
Biomarkers; 2021 Sep; 26(6):517-531. PubMed ID: 34082623
[TBL] [Abstract][Full Text] [Related]
18. Correlations of serum visfatin and metabolisms of glucose and lipid in women with gestational diabetes mellitus.
Liang Z; Wu Y; Xu J; Fang Q; Chen D
J Diabetes Investig; 2016 Mar; 7(2):247-52. PubMed ID: 27042278
[TBL] [Abstract][Full Text] [Related]
19. Plasma visfatin levels in pregnant women with normal glucose tolerance, gestational diabetes and pre-gestational diabetes mellitus.
Coskun A; Ozkaya M; Kiran G; Kilinc M; Arikan DC
J Matern Fetal Neonatal Med; 2010 Sep; 23(9):1014-8. PubMed ID: 20059442
[TBL] [Abstract][Full Text] [Related]
20. Elevated serum levels of visfatin in gestational diabetes: a comparative study across various degrees of glucose tolerance.
Lewandowski KC; Stojanovic N; Press M; Tuck SM; Szosland K; Bienkiewicz M; Vatish M; Lewinski A; Prelevic GM; Randeva HS
Diabetologia; 2007 May; 50(5):1033-7. PubMed ID: 17334748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
